The study by Duhen and colleagues showed that CD103 + CD39+ tumour-infiltrating CD8 T cells (CD8 TILs) were enriched for tumour-reactive cells in both primary and metastatic tumours. This evidence concerns the gene ENTPD1 and neoplasm.